Published in Invest Ophthalmol Vis Sci on November 01, 2007
Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest Ophthalmol Vis Sci (2008) 1.70
The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol (2012) 1.41
Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefes Arch Clin Exp Ophthalmol (2009) 1.10
At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement (2014) 1.02
Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension. PLoS One (2012) 1.01
Assessment of neuroprotection in the retina with DARC. Prog Brain Res (2008) 1.01
VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS One (2010) 0.93
Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes. Curr Eye Res (2010) 0.90
Amyloid precursor protein is required for normal function of the rod and cone pathways in the mouse retina. PLoS One (2012) 0.86
Pharmacotherapy of glaucoma. J Ocul Pharmacol Ther (2015) 0.84
The current research status of normal tension glaucoma. Clin Interv Aging (2014) 0.82
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrier. Sci Adv (2015) 0.82
Induction of amyloid-β(1-42) in the retina and optic nerve head of chronic ocular hypertensive monkeys. Mol Vis (2012) 0.80
Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Mol Psychiatry (2017) 0.76
Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection. Cell Death Dis (2016) 0.75
Differential roles of Aβ processing in hypoxia-induced axonal damage. Neurobiol Dis (2015) 0.75
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma. Front Neurosci (2017) 0.75
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci (2009) 3.19
BIGH3 mutation spectrum in corneal dystrophies. Invest Ophthalmol Vis Sci (2002) 2.19
Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. Am J Ophthalmol (2012) 1.87
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol (2006) 1.72
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina (2015) 1.67
Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae. Plant J (2005) 1.57
Dynamic contour tonometry in keratoconus and postkeratoplasty eyes. Cornea (2008) 1.50
Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci (2014) 1.46
Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci (2008) 1.42
Determination of microdot stromal degenerations within corneas of long-term contact lens wearers by confocal microscopy. Eye Contact Lens (2004) 1.39
Elaborate spatial patterning of cell-wall PME and PMEI at the pollen tube tip involves PMEI endocytosis, and reflects the distribution of esterified and de-esterified pectins. Plant J (2007) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Comparison and evaluation of ocular biometry using a new noncontact optical low-coherence reflectometer. Ophthalmology (2009) 1.30
Microcystic macular degeneration from optic neuropathy. Brain (2012) 1.27
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. Ophthalmology (2012) 1.26
A role for pectin de-methylesterification in a developmentally regulated growth acceleration in dark-grown Arabidopsis hypocotyls. New Phytol (2010) 1.23
Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol (2009) 1.23
Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci (2009) 1.20
Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17
The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model. Invest Ophthalmol Vis Sci (2009) 1.15
Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci (2012) 1.07
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated properties. Anal Chem (2012) 1.03
Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci (2011) 1.03
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients]. Klin Monbl Augenheilkd (2002) 1.03
The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther (2005) 1.01
Proprioception in total, hemi- and reverse shoulder arthroplasty in 3D motion analyses: a prospective study. Int Orthop (2008) 1.00
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
Ocular penetration of caspofungin in a rabbit uveitis model. Graefes Arch Clin Exp Ophthalmol (2006) 0.98
Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci (2007) 0.97
Local administration of an adeno-associated viral vector expressing IL-10 reduces monocyte infiltration and subsequent photoreceptor damage during experimental autoimmune uveitis. Mol Ther (2005) 0.97
In vivo pachymetry in normal eyes of rats, mice and rabbits with the optical low coherence reflectometer. Vision Res (2003) 0.96
Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica (2005) 0.96
Keratitis resulting from Thielavia subthermophila Mouchacca. Cornea (2009) 0.95
Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest Ophthalmol Vis Sci (2003) 0.95
Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia (2004) 0.94
Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother (2005) 0.94
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol (2013) 0.92
p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia (2008) 0.92
Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 0.92
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.91
Database supported candidate search for metabolite identification. J Integr Bioinform (2011) 0.91
Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol Vis (2005) 0.91
Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes. Curr Eye Res (2010) 0.90
Extracellular invertase is involved in the regulation of clubroot disease in Arabidopsis thaliana. Mol Plant Pathol (2010) 0.90
Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol (2003) 0.89
Long-term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with ranibizumab. Ophthalmologica (2013) 0.89
Bilateral angle-closure glaucoma after combined consumption of "ecstasy" and marijuana. Am J Emerg Med (2005) 0.89
External application of gametophyte-specific ZmPMEI1 induces pollen tube burst in maize. Plant Reprod (2013) 0.88
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.88
Evolution of HIV-1-related conjunctival molluscum contagiosum under HAART: report of a bilaterally manifesting case and literature review. Graefes Arch Clin Exp Ophthalmol (2004) 0.87
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
Intraocular pressure changes following 20G pars-plana vitrectomy. Acta Ophthalmol (2011) 0.86
Novel CACNA1A mutation(s) associated with slow saccade velocities. J Neurol (2013) 0.86
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study. Invest Ophthalmol Vis Sci (2012) 0.86
Genomewide homozygosity mapping and molecular analysis of a candidate gene located on 22q13 (fibulin-1) in a previously undescribed vitreoretinal dystrophy. Arch Ophthalmol (2003) 0.86
Prospective study of foveal thickness alterations after cataract surgery assessed by optical coherence tomography. Ophthalmologica (2012) 0.85
Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res (2006) 0.85
Expanding the cone location and magnitude index to include corneal thickness and posterior surface information for the detection of keratoconus. Am J Ophthalmol (2013) 0.85
Impact of optic media opacities and image compression on quantitative analysis of optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 0.85
Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci (2011) 0.84
Diversity of aquaporin mRNA expressed by rat and human retinas. Neuroreport (2005) 0.84
Bilateral central crystalline corneal deposits four years after intacs for myopia. J Refract Surg (2006) 0.84
Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol (2008) 0.83
Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration. Retina (2009) 0.82
Relevance of wide-field autofluorescence imaging in Birdshot retinochoroidopathy: descriptive analysis of 76 eyes. Acta Ophthalmol (2013) 0.82
Clinical comparison of biometry using the non-contact optical low coherence reflectometer (Lenstar LS 900) and contact ultrasound biometer (Tomey AL-3000) in cataract eyes. Br J Ophthalmol (2010) 0.82
Identification of P2Y receptor subtypes in human muller glial cells by physiology, single cell RT-PCR, and immunohistochemistry. Invest Ophthalmol Vis Sci (2005) 0.82
Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor. Cornea (2009) 0.82
Simple and objective method for routine detection of the macular pigment xanthophyll. J Biomed Opt (2011) 0.81
Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Fluorescence lifetime imaging in retinal artery occlusion. Invest Ophthalmol Vis Sci (2015) 0.80
Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration. Acta Ophthalmol (2012) 0.80
Can shoulder arthroplasty restore the range of motion in activities of daily living? A prospective 3D video motion analysis study. J Shoulder Elbow Surg (2010) 0.80
Impact of corneal cross-linking on drug penetration in an ex vivo porcine eye model. Cornea (2012) 0.80
Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration. Acta Ophthalmol (2009) 0.79
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids. Invest Ophthalmol Vis Sci (2015) 0.79
Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol (2007) 0.79
Complications after photodynamic therapy. Arch Ophthalmol (2005) 0.79
RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better. Retina (2016) 0.79
Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol (2006) 0.78
Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease. Lab Invest (2004) 0.78
Three-dimensional motion analysis of compensatory movements in patients with radioulnar synostosis performing activities of daily living. J Orthop Sci (2009) 0.78
Increased upconversion quantum yield in photonic structures due to local field enhancement and modification of the local density of states--a simulation-based analysis. Opt Express (2013) 0.78
Abnormal signalling of 14-3-3 proteins in cells with accumulated xanthurenic acid. Biochem Biophys Res Commun (2003) 0.78
[Eye injuries caused by "Hornussen"--a traditional Swiss team game]. Klin Monbl Augenheilkd (2003) 0.78
Rasagiline interferes with neurodegeneration in the Prph2/rds mouse. Retina (2012) 0.78
Detection of Chlamydia and complement factors in neovascular membranes of patients with age-related macular degeneration. Ocul Immunol Inflamm (2013) 0.78
Spectral-domain optical coherence tomography findings after severe exogenous endophthalmitis. Ocul Immunol Inflamm (2014) 0.77
Tocotrienol inhibits proliferation of human Tenon's fibroblasts in vitro: a comparative study with vitamin E forms and mitomycin C. Graefes Arch Clin Exp Ophthalmol (2005) 0.77
Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model. Antimicrob Agents Chemother (2002) 0.77